The improving narrative is supported by stable, positive market dynamics. Don t be surprised to see retail and others getting back into SPACs if the market continues this way.
SPAC Wrap: New Deal Duds, and QuantumScape Slammed by Short Seller Report
DEH and CHFW drummed up little investor enthusiasm for their SPAC merger announcements. SPAC IPOs remain parked and SPACs generally traded lower on the day. QS sold off on short seller report.
Author:
Apr 15, 2021
Two new deals were announced this morning, which felt like a lot of activity relative to what investors have become used to lately. However, neither of those deals, were met with much investor enthusiasm:
-
-
down 0.3%, and remains below NAV at $9.85
Perhaps it was a little bit of a risk-off sentiment in the market as both of the SPAC targets, Vicarious Surgical + Surrozen, are speculative pre-revenue healthcare plays.
The SEC is zeroing in on SPACS. Altimeter (AGC) is taking Grab public in a record breaking $40b dollar SPAC merger. SPACs with announced deals took it on the chin yesterday.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Noble Rock Acquisition Corporation Announces Pricing of Upsized $210 Million Initial Public Offering
February 2, 2021 GMT
WILMINGTON, Del. (BUSINESS WIRE) Feb 1, 2021
Noble Rock Acquisition Corporation (the “Company”) announced today that it priced its initial public offering of 21,000,000 units at $10.00 per unit. The units will be listed on The Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “NRACU” beginning February 2 nd, 2021. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants are exercisable. Once the securities comprising the units begin separate trading, the Class A ordinary shares and redeemable warrants are expected to be listed on Nasdaq under the symbols “NRAC” and �